From May 1984 through May 1987, the Cancer and Leukemia Group B (CALGB) conducted a randomized trial that showed that induction chemotherapy before radiation therapy improved survival during the first 3 years of follow-up.This report provides data for 7 years of follow-up of patients enrolled ...
Cancer stage has a lot of influence on survival rate, since higher survival rates are usually associated with earlier stages of the disease. To describe one's cancer stage physicians use the TNM Staging System which uses criteria that are similar for different types of cancer except malignancies ...
The present study analyzed the survival rate in patients with stage T2-T3a bladder cancer who had been treated by radical cystectomy. The records of 50 patients with T2-T3a NO tumor, submitted to pelvic lymphadenectomy and radical cystoprostatectomy, were reviewed to determine the prognosis in ...
Afatinib, an irreversible ErbB-family blocker, could improve the survival of advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patients (NSCLCm+). This phase II trial (NCT04201756) aimed to assess the feasibility of neoad
BackgroundThe survival rates for stage IIIA and stage IIIB Non–Small-cell lung cancer (NSCLC) are extremely poor with single-treatment modalities such as radiation therapy or surgery. The purpose of this study is to assess tolerability, response, surgical resectability, and survival of chemotherapy...
Stage migration secondary to meticulous lymph node dissection affects stage-specific survival rates. True therapeutic survival benefit of D3 resection can only be assessed in this context. 展开 关键词: Stage migration Gastric cancer Surgical randomised trial ...
Objective response rate OS: Overall survival CI: Confidence interval HR: Hazard ratio References Myall NJ, Das M. Advances in the treatment of Stage III Non-Small Cell Lung Cancer. Clin Chest Med. 2020;41(2):211–22. Article PubMed Google Scholar Godeau D, Petit A, Richard I, ...
3-week-scheduled combination chemotherapy of gemcitabine and cisplatin in patients with advanced NSCLC BACKGROUND: The combination chemotherapy of gemcitabine and cisplatin has been proven effective in the treatment of advanced non-small cell lung cancer (NSCLC). However, the optimal schedule for adminis...
When looking at the survival rate for stage 4 pancreatic cancer, the statistics are even worse. Just 3 percent of people with stage 4 pancreatic cancer will still be alive after five years. However, it's important to note that these numbers are based off historical data and there h...
Treatment, comorbidity and survival in stage III laryngeal cancer. Head Neck. 2015;37:698-706. https://doi.org/10. 1002/hed.23653.Katie L.Connor, SamuelPattle, Gillian R.Kerr, ElizabethJunor. (2015) Treatment, comorbidity and survival in stage III laryngeal cancer. Head & Neck 37 :...